{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:34:50Z","timestamp":1780666490982,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,6,30]],"date-time":"2013-06-30T00:00:00Z","timestamp":1372550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00213-013-3192-8","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T04:26:50Z","timestamp":1372480010000},"page":"515-524","source":"Crossref","is-referenced-by-count":39,"title":["Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports"],"prefix":"10.1007","volume":"228","author":[{"given":"W. Victor R.","family":"Vieweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrul","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules C.","family":"Hancox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baranchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve C.","family":"Digby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ericka L. Breden","family":"Crouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthi N.","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda K.","family":"Pandurangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,30]]},"reference":[{"issue":"5 Suppl 1","key":"3192_CR1","first-page":"1","volume":"43","author":"MM Bednar","year":"2001","unstructured":"Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN (2001) The QT interval. Prog Cardiovasc Dis 43(5 Suppl 1):1\u201345","journal-title":"Prog Cardiovasc Dis"},{"key":"3192_CR2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9149(02)02337-8","volume":"89","author":"MM Bednar","year":"2002","unstructured":"Bednar MM, Harrigan EP, Ruskin JN (2002) Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am J Cardiol 89:1316\u20131319","journal-title":"Am J Cardiol"},{"key":"3192_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1191\/096032701678766778","volume":"20","author":"AP Beelen","year":"2001","unstructured":"Beelen AP, Yeo KTJ, Lewis LD (2001) Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol 20:215\u2013219","journal-title":"Hum Exp Toxicol"},{"key":"3192_CR4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-2007-992147","volume":"40","author":"D Blaschke","year":"2007","unstructured":"Blaschke D, Parwani AS, Huemer M, Rolf S, Boldt LH, Dietz R, Haverkamp W (2007) Torsade de pointes during combined treatment with risperidone and citalopram. Pharmacopsychiatry 40:294\u2013295","journal-title":"Pharmacopsychiatry"},{"key":"3192_CR5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0196-0644(05)80421-4","volume":"22","author":"K Brown","year":"1993","unstructured":"Brown K, Levy H, Brenner C, Leffler S, Hamburg EL (1993) Overdose of risperidone. Ann Emerg Med 22:1908\u20131910","journal-title":"Ann Emerg Med"},{"key":"3192_CR6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1345\/aph.1R333","volume":"47","author":"AL Cartwright","year":"2013","unstructured":"Cartwright AL, Wilby KJ, Corrigan S, Ensom MH (2013) Pharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphisms. Ann Pharmacother 47:350\u2013360","journal-title":"Ann Pharmacother"},{"key":"3192_CR7","first-page":"184","volume":"17","author":"G Digby","year":"2010","unstructured":"Digby G, Machaalany J, Malik P, Methot M, Simpson CS, Redfearn D, Baranchuk A (2010) Multifactorial QT interval prolongation. Cardiol J 17:184\u2013188","journal-title":"Cardiol J"},{"key":"3192_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/clc.20945","volume":"34","author":"GC Digby","year":"2011","unstructured":"Digby GC, Perez Riera AR, Barbosa Barros R, Simpson CS, Redfearn DP, Methot M, Femenia F, Baranchuk A (2011) Acquired long QT interval: a case series of multifactorial QT prolongation. Clin Cardiol 34:577\u2013582","journal-title":"Clin Cardiol"},{"key":"3192_CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3928\/00485713-20130205-04","volume":"43","author":"M Doyle","year":"2013","unstructured":"Doyle M, Rosenthal LJ (2013) Psychotropic medications, associated QTc prolongation, and sudden cardiac death: a review for clinicians. Psychiatr Ann 43:58\u201365","journal-title":"Psychiatr Ann"},{"key":"3192_CR10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00005344-200306000-00016","volume":"41","author":"B Drolet","year":"2003","unstructured":"Drolet B, Yang T, Daleau P, Roden DM, Turgeon J (2003) Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. J Cardiovasc Pharmacol 41:934\u2013947","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 3","key":"3192_CR11","first-page":"S80","volume":"38","author":"L Ereshefsky","year":"1993","unstructured":"Ereshefsky L, Lacombe S (1993) Pharmacological profile of risperidone. Can J Psychiatr 38(Suppl 3):S80\u2013S88","journal-title":"Can J Psychiatr"},{"key":"3192_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.12.028","volume":"486","author":"AA Fossa","year":"2004","unstructured":"Fossa AA, Wisialowski T, Wolfgang E, Wang E, Avery M, Raunig DL, Fermini B (2004) Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig. Eur J Pharmacol 486:209\u2013221","journal-title":"Eur J Pharmacol"},{"key":"3192_CR13","first-page":"549","volume":"35","author":"LB Gesell","year":"1997","unstructured":"Gesell LB, Stephen M (1997) Toxicity following a single dose of risperidone for pediatric attention deficit hyperactivity disorder (ADHD). Clin Toxicol 35:549, Abstract #163","journal-title":"Clin Toxicol"},{"key":"3192_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2008.04.010","volume":"119","author":"GA Gintant","year":"2008","unstructured":"Gintant GA (2008) Preclinical torsades-de-pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk. Pharmacol Ther 119:199\u2013209","journal-title":"Pharmacol Ther"},{"key":"3192_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","volume":"119","author":"JC Hancox","year":"2008","unstructured":"Hancox JC, McPate MJ, El Harchi A, Zhang YH (2008) The hERG potassium channel and hERG screening for drug-induced torsades de pointes. Pharmacol Ther 119:118\u2013132","journal-title":"Pharmacol Ther"},{"key":"3192_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","volume":"24","author":"EP Harrigan","year":"2004","unstructured":"Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M (2004) A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 24:62\u201369","journal-title":"J Clin Psychopharmacol"},{"key":"3192_CR17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/01.CIR.86.5.1376","volume":"86","author":"JT Hii","year":"1992","unstructured":"Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB (1992) Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 86:1376\u20131382","journal-title":"Circulation"},{"key":"3192_CR18","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1540-8159.1998.tb00150.x","volume":"21","author":"B Houltz","year":"1998","unstructured":"Houltz B, Darp\u00d6 B, Edvardsson N, Blomstr\u00d6M PER, Brachmann J, Crijns HJGM, Jensen SM, Svernhage E, Vallin H, Swedberg K (1998) Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study. Pacing Clin Electrophysiol 21:1044\u20131057","journal-title":"Pacing Clin Electrophysiol"},{"key":"3192_CR19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.hrthm.2006.05.023","volume":"3","author":"JH Indik","year":"2006","unstructured":"Indik JH, Pearson EC, Fried K, Woosley RL (2006) Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Hear Rhythm 3:1003\u20131007","journal-title":"Hear Rhythm"},{"key":"3192_CR20","unstructured":"Janssen Pharmaceutica (2009) Risperdal package insert. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020272s056,020588s044,021346s033,021444s03lbl.pdf"},{"key":"3192_CR21","unstructured":"Janssen Pharmaceutica (2012) Risperdal Consta package insert. http:\/\/www.risperdalconsta.com\/sites\/default\/files\/RisperdalConstaPI.pdf#zoom=100"},{"key":"3192_CR22","first-page":"75","volume":"3","author":"M Kang","year":"2004","unstructured":"Kang M, Lesh B, Tampi R, Fajobi O, Ruedrich S, Schubert D (2004) Spotting a silent killer. Current Psychiatry 3:75\u201388","journal-title":"Current Psychiatry"},{"key":"3192_CR23","doi-asserted-by":"crossref","unstructured":"Kogut C, Crouse EB, Vieweg WVR, Hasnain M, Baranchuk A, Digby G, Koneru JN, Fernandez A, Deshmukh A, Hancox JC, Pandurangi AK (2013) SSRIs and torsade de pointes: new concepts and new directions derived from a systematic review of case reports. Ther Adv Drug Saf (in press)","DOI":"10.1177\/2042098613492366"},{"key":"3192_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","volume":"450","author":"S Kongsamut","year":"2002","unstructured":"Kongsamut S, Kang J, Chen XL, Roehr J, Rampe D (2002) A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur J Pharmacol 450:37\u201341","journal-title":"Eur J Pharmacol"},{"key":"3192_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-244X-12-220","volume":"12","author":"MJ Lazarczyk","year":"2012","unstructured":"Lazarczyk MJ, Bhuiyan ZA, Perrin N, Giannakopoulos P (2012) Selective acquired long QT syndrome (saLQTS) upon risperidone treatment. BMC Psychiatry 12:220","journal-title":"BMC Psychiatry"},{"key":"3192_CR26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1345\/aph.1E539","volume":"39","author":"V Marti","year":"2005","unstructured":"Marti V (2005) Sudden cardiac death due to risperidone therapy in a patient with possible hypertrophic cardiomyopathy. Ann Pharmacother 39:973","journal-title":"Ann Pharmacother"},{"key":"3192_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02245439","volume":"114","author":"AA Megens","year":"1994","unstructured":"Megens AA, Awouters FH, Schotte A, Meert TF, Dugovic C, Niemegeers CJ, Leysen JE (1994) Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology (Berl) 114:9\u201323","journal-title":"Psychopharmacology (Berl)"},{"key":"3192_CR28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1540-8159.2008.01085.x","volume":"31","author":"N-S Mok","year":"2008","unstructured":"Mok N-S, Tong C-K, Yuen H-C (2008) Concomitant-acquired long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia. PACE 31:772\u2013775","journal-title":"PACE"},{"key":"3192_CR29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.psy.44.6.521","volume":"44","author":"JJ Nandagopal","year":"2003","unstructured":"Nandagopal JJ, Craig JM, Lippmann S (2003) QTc prolongation: possible association with risperidone and\/or haloperidol. Psychosomatics 44:521","journal-title":"Psychosomatics"},{"key":"3192_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCEP.110.960658","volume":"4","author":"R Panikkath","year":"2011","unstructured":"Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R, Gunson K, Jui J, Chugh SS (2011) Prolonged Tpeak-to-Tend interval on the resting ECG is associated with increased risk of sudden cardiac death. Circ Arrhythmia Electrophysiol 4:441\u2013447","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"3192_CR31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/0091270010376973","volume":"51","author":"PT Pollak","year":"2011","unstructured":"Pollak PT, Verjee ZH, Lyon AW (2011) Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics. J Clin Pharmacol 51:1112\u20131115","journal-title":"J Clin Pharmacol"},{"key":"3192_CR32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pds.1746","volume":"18","author":"E Poluzzi","year":"2009","unstructured":"Poluzzi E, Raschi E, Moretti U, De Ponti F (2009) Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS). Pharmacoepidemiol Drug Saf 18:512\u2013518","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3192_CR33","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.hrthm.2008.03.037","volume":"5","author":"PG Postema","year":"2008","unstructured":"Postema PG, De Jong JSSG, Van der Bilt IAC, Wilde AAM (2008) Accurate electrocardiographic assessment of the QT interval: teach the tangent. Hear Rhythm 5:1015\u20131018","journal-title":"Hear Rhythm"},{"key":"3192_CR34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajp.2011.05.006","volume":"4","author":"F Rajabi","year":"2011","unstructured":"Rajabi F, Hajsheikholeslami F, Beyraghi N (2011) Sudden cardiac death after treatment with low dose risperidone in combination with cotrimoxazole. Asian J Psychiatry 4:218\u2013220","journal-title":"Asian J Psychiatry"},{"key":"3192_CR35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/106002809703100712","volume":"31","author":"DS Ravin","year":"1997","unstructured":"Ravin DS, Levenson JW (1997) Fatal cardiac event followng initiation of risperidone therapy. Ann Pharmacother 31:867\u2013870","journal-title":"Ann Pharmacother"},{"key":"3192_CR36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijcard.2006.04.069","volume":"116","author":"R Ravi\u00f1a","year":"2007","unstructured":"Ravi\u00f1a R, Guteirrez J, Ravi\u00f1a P (2007) Acquired long QT syndrome: long-term electrocardiographic (Holter) recording of torsades de pointes ending in asystole: II. Int J Cardiol 116:272\u2013275","journal-title":"Int J Cardiol"},{"key":"3192_CR37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00787-008-0699-3","volume":"18","author":"B Ritchie","year":"2009","unstructured":"Ritchie B, Norris ML (2009) QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa. J Can Acad Child Adolesc Psychiatry 18:60\u201363","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"3192_CR38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","volume":"21","author":"DM Roden","year":"1998","unstructured":"Roden DM (1998) Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: predicting torsades de pointes. Pacing Clin Electrophysiol 21:1029\u20131034","journal-title":"Pacing Clin Electrophysiol"},{"key":"3192_CR39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013\u20131022","journal-title":"N Engl J Med"},{"key":"3192_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2005.01.003","volume":"26","author":"MC Sanguinetti","year":"2005","unstructured":"Sanguinetti MC, Mitcheson JS (2005) Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci 26:119\u2013124","journal-title":"Trends Pharmacol Sci"},{"key":"3192_CR41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","volume":"440","author":"MC Sanguinetti","year":"2006","unstructured":"Sanguinetti MC, Tristani-Firouzi M (2006) hERG potassium channels and cardiac arrhythmia. Nature 440:463\u2013469","journal-title":"Nature"},{"key":"3192_CR42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2125.2002.01627.x","volume":"54","author":"RR Shah","year":"2002","unstructured":"Shah RR (2002) The significance of QT interval in drug development. Br J Clin Pharmacol 54:188\u2013202","journal-title":"Br J Clin Pharmacol"},{"key":"3192_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002018-200427030-00001","volume":"27","author":"RR Shah","year":"2004","unstructured":"Shah RR (2004) Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing. Drug Saf 27:145\u2013172","journal-title":"Drug Saf"},{"key":"3192_CR44","volume-title":"The black swan","author":"NN Taleb","year":"2010","unstructured":"Taleb NN (2010) The black swan, 2nd edn. Random House, New York","edition":"2"},{"key":"3192_CR45","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1176\/appi.psy.45.5.450","volume":"45","author":"Y Tei","year":"2004","unstructured":"Tei Y, Morita T, Inoue S, Miyata H (2004) Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient. Psychosomatics 45:450\u2013451","journal-title":"Psychosomatics"},{"key":"3192_CR46","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.hrthm.2012.12.002","volume":"10","author":"C Teodorescu","year":"2013","unstructured":"Teodorescu C, Reinier K, Uy-Evanado A, Chugh H, Gunson K, Jui J, Chugh SS (2013) Antipsychotic drugs are associated with pulseless electrical activity: the Oregon Sudden Unexpected Death Study. Hear Rhythm 10:526\u2013530","journal-title":"Hear Rhythm"},{"key":"3192_CR47","doi-asserted-by":"crossref","unstructured":"Titier K, Canal M, D\u00e9ridet E, Abouelfath A, Gromb S, Molimard M, Moore N (2004) Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol 199:52\u201360","DOI":"10.1016\/j.taap.2004.03.016"},{"key":"3192_CR48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.amjmed.2011.12.002","volume":"125","author":"WV Vieweg","year":"2012","unstructured":"Vieweg WV, Hasnain M, Howland RH, Hettema JM, Kogut C, Wood MA, Pandurangi AK (2012) Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Am J Med 125:859\u2013868","journal-title":"Am J Med"},{"key":"3192_CR49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/PCC.v05n0504","volume":"5","author":"WVR Vieweg","year":"2003","unstructured":"Vieweg WVR (2003) New generation antipsychotic drugs and QTc interval prolongation. Prim Care Companion J Clin Psychiatry 5:205\u2013215","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"3192_CR50","author":"WVR Vieweg","year":"2013","unstructured":"Vieweg WVR, Hasnain M, Howland RH, Clausen T, Koneru JN, Kogut C, Breden E, Hancox JC, Fernandez A, Pandurangi AK (2013) Methadone, QTc interval prolongation, and torsade de pointes: case reports offer clinicians the best guidance for this problem. Ther Adv Psychopharmacol. doi: 10.1177\/2045125312469982","journal-title":"Ther. Adv Psychopharmacol"},{"issue":"April","key":"3192_CR51","first-page":"50","volume":"28","author":"WVR Vieweg","year":"2011","unstructured":"Vieweg WVR, Hasnain M, Wood MA, Fernandez A, Lesnefsky EJ, Pandurangi AK (2011) Cardiometabolic risks of antidepressant and antipsychotic drugs, part 1: proarrhythmic risks of antidepressant and antipsychotic drugs. Psychiatr Times 28(April):50\u201355","journal-title":"Psychiatr Times"},{"key":"3192_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00023210-199707020-00004","volume":"7","author":"WVR Vieweg","year":"1997","unstructured":"Vieweg WVR, Leadbetter RA (1997) Polydipsia\u2013hyponatremia syndrome: epidemiology, clinical features, and treatment. CNS Drugs 7:121\u2013138","journal-title":"CNS Drugs"},{"key":"3192_CR53","first-page":"319","volume":"112","author":"WVR Vieweg","year":"2005","unstructured":"Vieweg WVR, Schneider RK, Wood MA (2005) Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine. Acta Psychiatr Scand 112:319\u2013323","journal-title":"Acta Psychiatr Scand"},{"key":"3192_CR54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.psy.45.5.371","volume":"45","author":"WVR Vieweg","year":"2004","unstructured":"Vieweg WVR, Wood MA (2004) Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics 45:371\u2013377","journal-title":"Psychosomatics"},{"key":"3192_CR55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/11318880-000000000-00000","volume":"26","author":"WVR Vieweg","year":"2009","unstructured":"Vieweg WVR, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK (2009) Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Drugs Aging 26:997\u20131012","journal-title":"Drugs Aging"},{"key":"3192_CR56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/FJC.0b013e318217d941","volume":"57","author":"P Vigneault","year":"2011","unstructured":"Vigneault P, Kaddar N, Bourgault S, Caillier B, Pilote S, Patoine D, Simard C, Drolet B (2011) Prolongation of cardiac ventricular repolarization under paliperidone: how and how much? J Cardiovasc Pharmacol 57:690\u2013695","journal-title":"J Cardiovasc Pharmacol"},{"key":"3192_CR57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.hrthm.2005.02.011","volume":"2","author":"S Viskin","year":"2005","unstructured":"Viskin S, Rosovski U, Sands AJ, Chen E, Kistler PM, Kalman JM, Chavez LR, Torres PI, Cruz FES, Centuri\u00a2n OA, Fujiki A, Maury P, Chen X, Krahn AD, Roithinger F, Zhang L, Vincent GM, Zeltser D (2005) Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Hear Rhythm 2:569\u2013574","journal-title":"Hear Rhythm"},{"key":"3192_CR58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20030010","volume":"105","author":"M Yamaguchi","year":"2003","unstructured":"Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, Mabuchi T, Konno T, Kaneda T, Mabuchi H (2003) T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci (London) 105:671\u2013676","journal-title":"Clin Sci (London)"},{"key":"3192_CR59","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ (2003) Drug induced QT prolongation and torsades de pointes. Heart 89:1363\u20131372","journal-title":"Heart"},{"key":"3192_CR60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4088\/JCP.v58n0705","volume":"58","author":"CA Zarate Jr","year":"1997","unstructured":"Zarate CA Jr, Baldessarini RJ, Siegel AJ, Nakamura A, McDonald J, Muir-Hutchinson LA, Cherkerzian T, Tohen M (1997) Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry 58:311\u2013317","journal-title":"J Clin Psychiatry"},{"key":"3192_CR61","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.102.23.2849","volume":"102","author":"L Zhang","year":"2000","unstructured":"Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A (2000) Spectrum of ST-T\u2013wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 102:2849\u20132855","journal-title":"Circulation"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3192-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3192-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T14:52:51Z","timestamp":1563288771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,30]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3192-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,30]]}}}